Creative BioMart has recently broadened its range of recombinant protein products to address the varied requirements of research endeavors across the globe. As a prominent biotechnology company known for providing top-notch protein products and services, Creative BioMart aims to enhance its offerings in the realm of recombinant proteins to better serve the scientific community. Recombinant proteins are proteins that can be altered due to their encoding by recombinant DNA, which has been cloned into an external expression system for the purpose of producing exogenous genes. This manipulation allows for the creation of a diverse array of valuable protein products that can be utilized in various research applications.
With a focus on achieving high levels of protein expression, Creative BioMart customizes recombinant DNA, often employing the cDNA sequence of the target protein, to enable the expression of the desired protein within specific host cells under the regulation of a defined promoter. Presently, Creative BioMart offers an extensive catalog of over 100,000 recombinant protein products covering a wide spectrum of genes, catering to the needs of researchers worldwide. In response to the evolving demands of its clientele, the company has expanded its product categories to include cytokines, PROTAC targets, GPCRS, Avi-tagged proteins, full-length proteins, CD antigens, and more.
The recombinant protein offerings from Creative BioMart are characterized by a range of features, as highlighted on the company’s official website. These include broad species coverage encompassing human, mouse, rat, rabbit, pig, monkey, dog, chicken, zebrafish, and others; utilization of multiple expression systems such as HEK293, CHO, E. coli, yeast, insect cells like Sf9/Sf21, wheat germ, NS0, among others; provision of flexible protein formats including fragments, full-length proteins, engineered variants, and mutants; and incorporation of various affinity tags like His, GST, Fc, Flag, HA, T7, MYC, Strep, and more at the N- or C-terminus to facilitate downstream applications.
In response to the global transmission of the chikungunya virus across numerous countries and regions, Creative BioMart has introduced recombinant E1 and E2 proteins along with other associated proteins to aid in the development of chikungunya virus vaccines, antiviral medications, and diagnostic tools. Notable products in this category include Recombinant CHIKV E2/Envelope 2 Protein, His-tagged; Recombinant CHIKV (strain SL-CK1) E2 protein (Ser326-Gln666), His-tagged; Recombinant Chikungunya CHIKV E1 Mutant (A226V) Protein; and Recombinant CHIKV E1 Envelope Protein. By expanding its repertoire to encompass more than 20 protein expression systems, Creative BioMart is equipped to provide customized solutions for intricate projects in drug discovery, diagnostics, and therapeutic research.
In recognition of the unwavering support from its customers, Creative BioMart has announced a limited-time offer of 15% off on its range of recombinant protein products. This initiative aims to express gratitude for the continued patronage and trust placed in the company by the research community. For further insights into the comprehensive list of recombinant protein products available at Creative BioMart, interested parties are encouraged to visit the company’s website for detailed information. By consistently enhancing its offerings and tailoring solutions to meet diverse research needs, Creative BioMart remains at the forefront of providing innovative tools and resources for scientific exploration.
- Creative BioMart has expanded its recombinant protein product line to cater to a wide range of research requirements.
- The company offers over 100,000 recombinant proteins covering various genes and has diversified its product categories to include cytokines, PROTAC targets, GPCRS, Avi-tagged proteins, and more.
- Recombinant proteins from Creative BioMart feature broad species coverage, multiple expression systems, flexible protein formats, and various affinity tags to support diverse research applications.
- In response to the global prevalence of the chikungunya virus, the company has introduced specific recombinant proteins to aid in the development of vaccines, antiviral drugs, and diagnostic tools.
Tags: yeast
Read more on news.marketersmedia.com